Grading cardiac response in AL amyloidosis: implications for relapse and survival

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria

(2018) Eli Muchtar et al.   LEUKEMIA

Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies

(2015) Efstathios Kastritis et al.   AMERICAN JOURNAL OF HEMATOLOGY

Natural history and therapy of AL cardiac amyloidosis

(2014) Martha Grogan et al.   HEART FAILURE REVIEWS

New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

(2012) Giovanni Palladini et al.   JOURNAL OF CLINICAL ONCOLOGY

Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis

(2012) R L Comenzo et al.   LEUKEMIA

Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score

(2010) Shaji K. Kumar et al.   MAYO CLINIC PROCEEDINGS